← FDA DRUG APPROVALS

FDA ANDA · ANDA064141

AMPHOTERICIN B

Sponsor: ABBOTT

APPLICATION
ANDA064141
TYPE
ANDA
ORIGINAL APPROVAL
1996-12-23
LATEST ACTION
2001-02-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMPHOTERICIN BDiscontinued
AMPHOTERICIN B 50MG/VIAL · INJECTABLE · INJECTION

Approval history

2001-02-14Manufacturing (CMC) · Supplement 1AP
1996-12-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →